オートインジェクター市場：治療法、製品タイプ、用途、エンドユーザー別-2025～2030年の世界予測

オートインジェクター市場は、2023年に673億9,000万米ドルと評価され、2024年には806億2,000万米ドルに達すると予測され、CAGR 19.72％で成長し、2030年には2,377億米ドルになると予測されています。

オートインジェクター市場には、薬剤の自己投与用に設計されたデバイスが含まれ、主に急性のアレルギー反応や関節リウマチ、多発性硬化症などの慢性疾患の緩和に重点が置かれています。これらのデバイスは、正確な投与量を提供し、患者のコンプライアンスを強化し、個人が独立して健康状態を管理できるようにするために不可欠です。救急医療、在宅医療、病院などさまざまなセグメントで応用されており、エンドユーザーは個人の患者から大規模な医療プロバイダーまで多岐にわたります。慢性疾患の有病率の上昇、アナフィラキシー事故の増加、ドラッグデリバリーシステムの技術的進歩が市場の成長を後押ししています。さらに、特に新興国における生物製剤とバイオシミラーの需要拡大が、有利な機会をもたらしています。オートインジェクターにおける移植性、使いやすさ、安全性メカニズムの強化は、患者と投資家の双方から大きな関心を集めています。

しかし、オートインジェクターの高価格、規制上のハードル、世界的に多様な患者ニーズに対応するための一貫した製品イノベーションの必要性などの要因により、市場成長は阻害されています。さらに、浸透していない市場におけるオートインジェクターの認知度の低さも課題となっています。このような障害にもかかわらず、遠隔医療やデジタルヘルスプラットフォームの拡大により、オートインジェクターの普及が促進され、メーカーには大きな成長の道が開けています。市場の潜在力を活用するために、企業はIoTのようなスマート技術を統合し、投与量の追跡や接続性といった先進的機能を提供することに注力すべきです。調査は、デバイスの小型化、投薬の安定性向上、環境問題に対処するための環境に優しい設計を対象とすべきです。全体として、オートインジェクター市場は技術革新と患者中心の進歩に牽引されたダイナミックな市場であるが、サステイナブル成長を達成するためには規制状況やコスト面での課題を戦略的に克服する必要があります。

市場力学：急速に進化するオートインジェクター市場の主要市場洞察を公開

オートインジェクター市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人口におけるアナフィラキシーの有病率の上昇
  • 注射の自己投与志向の高まり
  • オンライン薬局チャネルによる普及
• 市場抑制要因
  • オートインジェクターデバイスの安全性と使いやすさに関する問題
• 市場機会
  • オートインジェクターのデザインと技術の向上
  • 在宅医療サービスの普及拡大
• 市場課題
  • 厳しい規制と承認要件

ポーターのファイブフォース：オートインジェクター市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：オートインジェクター市場における外部からの影響の把握

外部マクロ環境要因は、オートインジェクター市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：オートインジェクター市場における競合情勢の把握

オートインジェクター市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：オートインジェクター市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、オートインジェクター市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：オートインジェクター市場における成功への道筋を描く

オートインジェクター市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人口におけるアナフィラキシーの有病率の上昇
    • 注射の自己投与への傾向の高まり
    • オンライン薬局チャネルを通じて広く入手可能
  • 抑制要因
    • オートインジェクターデバイスの安全性と使いやすさに関する問題
  • 機会
    • オートインジェクターの設計と技術の改善
    • 在宅医療サービスの普及率向上
  • 課題
    • 厳格な規制と承認要件
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 オートインジェクター市場セラピー

• イントロダクション
• アナフィラキシー
• 糖尿病
• 多発性硬化症
• 関節リウマチ

第7章 オートインジェクター市場：製品タイプ別

• イントロダクション
• 使い捨てオートインジェクター
• 再利用可能オートインジェクター
  • 空
  • プレフィルド

第8章 オートインジェクター市場：用途別

• イントロダクション
• アナフィラキシー
• 貧血
• 心血管疾患
• 糖尿病
• 偏頭痛
• 多発性硬化症
• 乾癬
• 関節リウマチ

第9章 オートインジェクター市場：エンドユーザー別

• イントロダクション
• 外来手術センター
• 在宅医療
• 病院・クリニック

第10章 南北アメリカのオートインジェクター市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のオートインジェクター市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのオートインジェクター市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Amgen Inc.
• Antares Pharma, Inc.
• AstraZeneca PLC
• Bayer AG
• Becton, Dickinson and Company
• Biogen Inc.
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline PLC
• Harro Hofliger Verpackungsmaschinen GmbH
• Johnson & Johnson Services, Inc.
• Medeca Pharma AB
• Merck KGaA
• Mylan N.V. by Viatris Inc.
• NEMERA Group
• Novartis AG
• Pfizer, Inc.
• Ravimed Sp. z o.o.
• Recipharm AB
• Sanofi S.A.
• SHL Medical AG
• Stevanato Group
• Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

• FIGURE 1. AUTO-INJECTORS MARKET RESEARCH PROCESS
• FIGURE 2. AUTO-INJECTORS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL AUTO-INJECTORS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. AUTO-INJECTORS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL AUTO-INJECTORS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. AUTO-INJECTORS MARKET DYNAMICS
• TABLE 7. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL AUTO-INJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISPOSABLE AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL AUTO-INJECTORS MARKET SIZE, BY EMPTY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PREFILLED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL AUTO-INJECTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MIGRAINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL AUTO-INJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL AUTO-INJECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CANADA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 48. CANADA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CANADA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 50. CANADA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. CHINA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 75. CHINA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. CHINA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 77. CHINA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. CHINA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. INDIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 80. INDIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. INDIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 82. INDIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. ITALY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 166. ITALY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 167. ITALY AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 168. ITALY AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. ITALY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. POLAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 186. POLAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 187. POLAND AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 188. POLAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. POLAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. QATAR AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 191. QATAR AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 192. QATAR AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 193. QATAR AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. QATAR AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 240. AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 241. AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, 2023

The Auto-Injectors Market was valued at USD 67.39 billion in 2023, expected to reach USD 80.62 billion in 2024, and is projected to grow at a CAGR of 19.72%, to USD 237.70 billion by 2030.

The auto-injectors market encompasses devices designed for self-administration of drugs, primarily focusing on alleviating acute allergic reactions and chronic conditions like rheumatoid arthritis or multiple sclerosis. These devices are essential for delivering precise dosages, enhancing patient compliance, and empowering individuals to manage their health conditions independently. They are applied across various sectors, including emergency care, home healthcare, and hospitals, with end-users ranging from individual patients to large healthcare providers. The rising prevalence of chronic ailments, increasing anaphylaxis incidents, and technological advances in drug delivery systems fuel market growth. Moreover, the growing demand for biologics and biosimilars, especially in emerging economies, offers lucrative opportunities. Enhanced portability, usability, and safety mechanisms in auto-injectors are attracting substantial interest from both patients and investors.

However, market growth is impeded by factors such as the high cost of auto-injectors, regulatory hurdles, and the need for consistent product innovation to meet diverse patient needs globally. Additionally, the lack of awareness about auto-injectors in underpenetrated markets poses a challenge. Despite these obstacles, the expansion of telemedicine and digital health platforms facilitates the broader adoption of auto-injectors, presenting manufacturers with a significant growth avenue. To capitalize on market potential, companies should focus on integrating smart technologies, like IoT, to offer advanced features such as dosage tracking and connectivity. Research should target device miniaturization, improved medication stabilization, and eco-friendly designs to address environmental concerns. Overall, the auto-injector market is dynamic, driven by innovation and patient-centric advancements, but requires strategic navigation of regulatory landscapes and cost challenges to achieve sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Auto-Injectors Market

The Auto-Injectors Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of anaphylaxis among population
  • Growing inclination towards self-administration of injections
  • Widespread availability through online pharmacy channels
• Market Restraints
  • Issues pertaining to the safety and usability of auto-injectors devices
• Market Opportunities
  • Improvement in auto injector designs and technology
  • Increasing penetration of home-care health services
• Market Challenges
  • Stringent regulatory and approval requirements

Porter's Five Forces: A Strategic Tool for Navigating the Auto-Injectors Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Auto-Injectors Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Auto-Injectors Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Auto-Injectors Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Auto-Injectors Market

A detailed market share analysis in the Auto-Injectors Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Auto-Injectors Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Auto-Injectors Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Auto-Injectors Market

A strategic analysis of the Auto-Injectors Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Auto-Injectors Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., Antares Pharma, Inc., AstraZeneca PLC, Bayer AG, Becton, Dickinson and Company, Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Harro Hofliger Verpackungsmaschinen GmbH, Johnson & Johnson Services, Inc., Medeca Pharma AB, Merck KGaA, Mylan N.V. by Viatris Inc., NEMERA Group, Novartis AG, Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, Sanofi S.A., SHL Medical AG, Stevanato Group, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Auto-Injectors Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Therapy, market is studied across Anaphylaxis, Diabetes, Multiple Sclerosis, and Rheumatoid Arthritis.
• Based on Product Type, market is studied across Disposable Auto-Injectors and Reusable Auto-Injectors. The Reusable Auto-Injectors is further studied across Empty and Prefilled.
• Based on Application, market is studied across Anaphylaxis, Anemia, Cardiovascular Diseases, Diabetes, Migraines, Multiple Sclerosis, Psoriasis, and Rheumatoid Arthritis.
• Based on End-user, market is studied across Ambulatory Surgical Centers, Homecare Settings, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of anaphylaxis among population
    • 5.1.1.2. Growing inclination towards self-administration of injections
    • 5.1.1.3. Widespread availability through online pharmacy channels
  • 5.1.2. Restraints
    • 5.1.2.1. Issues pertaining to the safety and usability of auto-injectors devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Improvement in auto injector designs and technology
    • 5.1.3.2. Increasing penetration of home-care health services
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory and approval requirements
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Auto-Injectors Market, by Therapy

• 6.1. Introduction
• 6.2. Anaphylaxis
• 6.3. Diabetes
• 6.4. Multiple Sclerosis
• 6.5. Rheumatoid Arthritis

7. Auto-Injectors Market, by Product Type

• 7.1. Introduction
• 7.2. Disposable Auto-Injectors
• 7.3. Reusable Auto-Injectors
  • 7.3.1. Empty
  • 7.3.2. Prefilled

8. Auto-Injectors Market, by Application

• 8.1. Introduction
• 8.2. Anaphylaxis
• 8.3. Anemia
• 8.4. Cardiovascular Diseases
• 8.5. Diabetes
• 8.6. Migraines
• 8.7. Multiple Sclerosis
• 8.8. Psoriasis
• 8.9. Rheumatoid Arthritis

9. Auto-Injectors Market, by End-user

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Homecare Settings
• 9.4. Hospitals & Clinics

10. Americas Auto-Injectors Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Auto-Injectors Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Auto-Injectors Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Amgen Inc.
• 3. Antares Pharma, Inc.
• 4. AstraZeneca PLC
• 5. Bayer AG
• 6. Becton, Dickinson and Company
• 7. Biogen Inc.
• 8. Bristol-Myers Squibb Company
• 9. Eli Lilly and Company
• 10. F. Hoffmann-La Roche Ltd.
• 11. GlaxoSmithKline PLC
• 12. Harro Hofliger Verpackungsmaschinen GmbH
• 13. Johnson & Johnson Services, Inc.
• 14. Medeca Pharma AB
• 15. Merck KGaA
• 16. Mylan N.V. by Viatris Inc.
• 17. NEMERA Group
• 18. Novartis AG
• 19. Pfizer, Inc.
• 20. Ravimed Sp. z o.o.
• 21. Recipharm AB
• 22. Sanofi S.A.
• 23. SHL Medical AG
• 24. Stevanato Group
• 25. Teva Pharmaceutical Industries Ltd.